Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy

References

• Lin YK, Gao B, Liu L, et al. The prevalence of diabetic microvascular complications in China and the USA. Curr Diab Rep. 2021;21(6):16. doi:10.1007/s11892-021-01387-3
   PubMed Web of Science ®Google Scholar
• Klessens CQ, Woutman TD, Veraar KA, et al. An autopsy study suggests that diabetic nephropathy is underdiagnosed. Kidney Int. 2016;90(1):149–156. doi:10.1016/j.kint.2016.01.023
   PubMed Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045. doi:10.2215/CJN.11491116
   PubMed Web of Science ®Google Scholar
• Fu J, Sun Z, Wang X, et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022;102(6):1291–1304. doi:10.1016/j.kint.2022.08.026
   PubMed Web of Science ®Google Scholar
• Su S, Ma Z, Wu H, Xu Z, Yi H. Oxidative stress as a culprit in diabetic kidney disease. Life Sci. 2023;322:121661. doi:10.1016/j.lfs.2023.121661
   PubMed Web of Science ®Google Scholar
• Tekce H, Tekce BK, Aktas G, Alcelik A, Sengul E. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease. Exper Clin Endocrinol Diabetes. 2014;122(8):451–456. doi:10.1055/s-0034-1375674
   PubMed Web of Science ®Google Scholar
• Kin Tekce B, Tekce H, Aktas G, Sit M. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy. Clin Invest Med. 2014;37(6):E377–E383. doi:10.25011/cim.v37i6.22242
   PubMed Web of Science ®Google Scholar
• Bilgin S, Kurtkulagi O, Atak Tel BM, et al. Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with type 2 dIabetes mellitus? The CARE TIME study. Prim Care Diabetes. 2021;15(6):1071–1074. doi:10.1016/j.pcd.2021.08.015
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, Duman TT, Atak BM, Savli H. Mean platelet volume to lymphocyte ratio as a novel marker for diabetic nephropathy. J Coll Physicians Surg Pak. 2018;28(11):844–847. doi:10.29271/jcpsp.2018.11.844
   PubMed Web of Science ®Google Scholar
• Taslamacioglu Duman T, Ozkul FN, Balci B. Could systemic inflammatory index predict diabetic kidney injury in type 2 diabetes mellitus? Diagnostics. 2023;13(12):2063. doi:10.3390/diagnostics13122063
   Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Duman TT, et al. Monocyte lymphocyte ratio as a predictor of diabetic kidney injury in type 2 diabetes mellitus; The MADKID Study. J. Diabetes Metab Disord. 2020;19(2):997–1002. doi:10.1007/s40200-020-00595-0
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Atak BM, et al. Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 2020;50(3):e13206. doi:10.1111/eci.13206
   PubMed Web of Science ®Google Scholar
• Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi:10.1080/00325481.2023.2214058
   PubMed Web of Science ®Google Scholar
• Huang B, Wen W, Ye S. Correlation between serum 25-Hydroxyvitamin D levels in albuminuria progression of diabetic kidney disease and underlying mechanisms by bioinformatics analysis. Front Endocrinol. 2022;13:880930. doi:10.3389/fendo.2022.880930
   PubMed Web of Science ®Google Scholar
• Chen C, Liu L, Luo J. Identification of the molecular mechanism and candidate markers for diabetic nephropathy. Ann Transl Med. 2022;10(22):1248. doi:10.21037/atm-22-5128
   PubMedGoogle Scholar
• Ray JD, Kener KB, Bitner BF, et al. Nkx6.1-mediated insulin secretion and β-cell proliferation is dependent on upregulation of c-Fos. FEBS Letters. 2016;590(12):1791–1803. doi:10.1002/1873-3468.12208
   PubMed Web of Science ®Google Scholar
• Liang F, Luo YF, Guo Z, Qian Q, Meng XB, Mo ZH. MicroRNA-139-5p mediates BMSCs impairment in diabetes by targeting HOXA9/c-Fos. FASEB J. 2023;37(1):e22697. doi:10.1096/fj.202201059R
   PubMed Web of Science ®Google Scholar
• Ding S, Gan T, Xiang Y, et al. FOS gene associated immune infiltration signature in perivascular adipose tissues of abdominal aortic aneurysm. Gene. 2022;831:146576. doi:10.1016/j.gene.2022.146576
   PubMed Web of Science ®Google Scholar
• Zhu J, Yao K, Guo J, et al. miR-181a and miR-150 regulate dendritic cell immune inflammatory responses and cardiomyocyte apoptosis via targeting JAK1-STAT1/c-Fos pathway. J Cell Mol Med. 2017;21(11):2884–2895. doi:10.1111/jcmm.13201
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;149:w20139.
   PubMed Web of Science ®Google Scholar
• Aktas G. Association between the prognostic nutritional index and chronic microvascular complications in patients with type 2 diabetes mellitus. J Clin Med. 2023;12(18):5952. doi:10.3390/jcm12185952
   PubMed Web of Science ®Google Scholar
• Hudson LK, Dancho ME, Li J, et al. Emetine Di-HCl attenuates type 1 diabetes mellitus in mice. Mol Med. 2016;22(1):585–596. doi:10.2119/molmed.2016.00082
   PubMedGoogle Scholar
• Umanath K, Lewis JB. Update on Diabetic Nephropathy: core Curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895. doi:10.1053/j.ajkd.2017.10.026
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Chen L, et al. Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct Target Ther. 2021;6(1):409. doi:10.1038/s41392-021-00805-y
   PubMed Web of Science ®Google Scholar
• Kim DY, Kang MK, Kim YH, et al. Eucalyptol ameliorates dysfunction of actin cytoskeleton formation and focal adhesion assembly in glucose-loaded podocytes and diabetic kidney. Mol Nutr Food Res. 2019;63(22):e1900489. doi:10.1002/mnfr.201900489
   PubMed Web of Science ®Google Scholar
• Hu C, Sun L, Xiao L, et al. Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy. Curr Med Chem. 2015;22(24):2858–2870. doi:10.2174/0929867322666150625095407
   PubMed Web of Science ®Google Scholar
• Su WY, Li Y, Chen X, et al. Ginsenoside Rh1 improves type 2 diabetic nephropathy through AMPK/PI3K/Akt-mediated inflammation and apoptosis signaling pathway. Am J Chin Med. 2021;49(5):1215–1233. doi:10.1142/S0192415X21500580
   PubMedGoogle Scholar
• Xu Z, Jia K, Wang H, et al. METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease. Cell Death Dis. 2021;12(1):32. doi:10.1038/s41419-020-03312-0
   PubMed Web of Science ®Google Scholar
• Chen A, Liu Y, Lu Y, Lee K, He JC. Disparate roles of retinoid acid signaling molecules in kidney disease. Am J Physiol Renal Physiol. 2021;320(5):F683–F692. doi:10.1152/ajprenal.00045.2021
   PubMed Web of Science ®Google Scholar
• Huang K, Huang J, Chen C, et al. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose. Cell Signalling. 2014;26(3):629–638. doi:10.1016/j.cellsig.2013.12.002
   PubMed Web of Science ®Google Scholar
• Wei R, Qiao J, Cui D, Pan Q, Guo L. Screening and identification of hub genes in the development of early diabetic kidney disease based on weighted gene co-expression network analysis. Front Endocrinol. 2022;13:883658. doi:10.3389/fendo.2022.883658
   PubMed Web of Science ®Google Scholar
• Bhattacharjee N, Barma S, Konwar N, Dewanjee S, Manna P. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update. Eur J Pharmacol. 2016;791:8–24. doi:10.1016/j.ejphar.2016.08.022
   PubMed Web of Science ®Google Scholar
• Shen S, Ji C, Wei K. Cellular senescence and regulated cell death of tubular epithelial cells in diabetic kidney disease. Front Endocrinol. 2022;13:924299. doi:10.3389/fendo.2022.924299
   PubMed Web of Science ®Google Scholar
• Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 2020;16(4):206–222. doi:10.1038/s41581-019-0234-4
   PubMed Web of Science ®Google Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144–158. doi:10.1038/s41581-019-0110-2
   PubMed Web of Science ®Google Scholar
• Feng X, Gao X, Wang S, et al. PPAR-α agonist fenofibrate prevented diabetic nephropathy by inhibiting M1 macrophages via improving endothelial cell function in db/db mice. Front Med. 2021;8:652558. doi:10.3389/fmed.2021.652558
   Web of Science ®Google Scholar
• Guiteras R, Sola A, Flaquer M, Manonelles A, Hotter G, Cruzado JM. Exploring macrophage cell therapy on Diabetic Kidney Disease. J Cell Mol Med. 2019;23(2):841–851. doi:10.1111/jcmm.13983
   PubMed Web of Science ®Google Scholar
• Boels MGS, Koudijs A, Avramut MC, et al. Systemic monocyte chemotactic protein-1 inhibition modifies renal macrophages and restores glomerular endothelial glycocalyx and barrier function in diabetic nephropathy. Am J Pathol. 2017;187(11):2430–2440. doi:10.1016/j.ajpath.2017.07.020
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen J, Li YY, Xia LL, Wu YG. Bruton’s tyrosine kinase regulates macrophage‑induced inflammation in the diabetic kidney via NLRP3 inflammasome activation. Int J Mol Med. 2021;48(3). doi:10.3892/ijmm.2021.5010
   Web of Science ®Google Scholar
• Ito S, Nakashima H, Ishikiriyama T, et al. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy. Am J Physiol Renal Physiol. 2021;321(6):F757–F770. doi:10.1152/ajprenal.00191.2021
   PubMed Web of Science ®Google Scholar
• Ma T, Li X, Zhu Y, et al. Excessive activation of notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis. Front Immunol. 2022;13:835879. doi:10.3389/fimmu.2022.835879
   PubMed Web of Science ®Google Scholar
• Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Mol Metabol. 2019;23:24–36. doi:10.1016/j.molmet.2019.02.007
   PubMed Web of Science ®Google Scholar